Primary Cutaneous Polymorphic EBV-Associated Posttransplant Lymphoproliferative Disorder After a Renal Transplant and Review of the Literature
- PMID: 25747810
- DOI: 10.1097/DAD.0000000000000272
Primary Cutaneous Polymorphic EBV-Associated Posttransplant Lymphoproliferative Disorder After a Renal Transplant and Review of the Literature
Abstract
Importance: Posttransplant lymphoproliferative disorder (PTLD) is an uncommon complication after solid organ transplants and hematopoietic stem cell transplants. Extranodal involvement in PTLD can involve several organ systems, including the central nervous system, bone marrow, lungs, gastrointestinal tract, and skin. Isolated involvement of the skin without systemic involvement in PTLD is rare. Primary cutaneous PTLD is generally categorized as either cutaneous T-cell lymphomas or cutaneous B-cell lymphomas, with variable Epstein-Barr virus (EBV) positivity. Herein, we describe an exceedingly uncommon case of a polymorphic variant of primary cutaneous PTLD.
Observations: A woman in her 30s, who received an EBV+ deceased donor kidney transplant, presented with a 2-week history of 2 indurated patches over the lower abdomen. A skin biopsy revealed an atypical lymphoid proliferation with immunohistochemical stains demonstrating a mixed population of both B and T cells that stained strongly positive for EBV-encoded RNA. A bone marrow biopsy and positron emission tomography/computed tomography were negative for systemic involvement. The patient was treated with immunosuppression reduction and rituximab infusions.
Conclusions and relevance: This case highlights a rare polymorphic variant of primary cutaneous EBV-associated PTLD and increases awareness of this uncommon posttransplant complication. Cutaneous PTLD is reviewed, therefore dermatologists are aware of this uncommon disorder.
Similar articles
-
EBV-positive mucocutaneous ulcer in organ transplant recipients: a localized indolent posttransplant lymphoproliferative disorder.Am J Surg Pathol. 2014 Nov;38(11):1522-9. doi: 10.1097/PAS.0000000000000282. Am J Surg Pathol. 2014. PMID: 25007145
-
Response to rituximab-based therapy and risk factor analysis in Epstein Barr Virus-related lymphoproliferative disorder after hematopoietic stem cell transplant in children and adults: a study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.Clin Infect Dis. 2013 Sep;57(6):794-802. doi: 10.1093/cid/cit391. Epub 2013 Jun 13. Clin Infect Dis. 2013. PMID: 23771985
-
Epstein-Barr virus-positive mucocutaneous ulcer arising in a post-hematopoietic cell transplant patient followed by polymorphic posttransplant lymphoproliferative disorder and cytomegalovirus colitis.Hum Pathol. 2017 Jan;59:147-151. doi: 10.1016/j.humpath.2016.08.001. Epub 2016 Aug 26. Hum Pathol. 2017. PMID: 27569297
-
Recurrent posttransplant lymphoproliferative disorder involving the larynx and trachea: case report and review of the literature.Ann Otol Rhinol Laryngol. 2012 May;121(5):291-5. doi: 10.1177/000348941212100502. Ann Otol Rhinol Laryngol. 2012. PMID: 22724273 Review.
-
The Immune Response to Epstein Barr Virus and Implications for Posttransplant Lymphoproliferative Disorder.Transplantation. 2017 Sep;101(9):2009-2016. doi: 10.1097/TP.0000000000001767. Transplantation. 2017. PMID: 28376031 Free PMC article. Review.
Cited by
-
Epstein-Barr Virus-Associated Lymphomatoid Papules: A Sign of Immunosuppression Resembling Lymphomatoid Papulosis.Am J Dermatopathol. 2023 Dec 1;45(12):789-800. doi: 10.1097/DAD.0000000000002479. Am J Dermatopathol. 2023. PMID: 37982462 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical